Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-25 @ 7:43 PM
Study NCT ID:
NCT05495035
Status:
UNKNOWN
Last Update Posted:
2023-03-02
First Post:
2022-08-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-08
First Submit QC Date:
None
Study First Post Date:
2022-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-01
Last Update Post Date:
2023-03-02
Last Update Post Date Type:
ACTUAL